Developer docs
API playgroundTry for free, no card

Search company profiles

MWI Animal Health

Full company profile

uuid000a1yl

Namestring
MWI Animal Health
Legal namestring
MWI Veterinary Supply Co., d/b/a MWI Animal Health
Websiteurl
mwiah.com
Company typeenum
Private
Founded yearint
1976
Short descriptiontext

MWI Animal Health is a US-based animal health distributor and technology solutions provider, wholly owned by Cencora, serving veterinary practices, livestock producers, and manufacturers with 25,000+ stocked SKUs and SaaS workflow tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBoise, United States
HQ citystring
Boise
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal health distribution, veterinary pharmaceuticals, veterinary supply chain, livestock health products, veterinary practice solutions
Industry4 codes
1Veterinary Pharmaceutical Wholesalers & Distributors
CodeHLAMAIAAPrimaryYes
2Veterinary Vaccine & Biologics Distributors
CodeHLAMAIACPrimaryNo
3Veterinary Inventory, Pharmacy & Medication Management
CodeHLAMAMAFPrimaryNo
4Animal Health Supply Chain, Procurement & Distributor Connectivity
CodeHLAMAMAKPrimaryNo
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Veterinary Pharmaceutical Distribution
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Animal Health Product Distribution
TypeTransaction Fee
Description

MWI distributes over 25,000 stocked products and 30,000+ drop-ship products from 1,000+ manufacturer partners to veterinary practices, livestock producers, and animal health manufacturers. Revenue is generated through product sales at margins typical of distribution, with payment terms including open account (due by 10th of month following invoice) and credit card options.

mwiah.com
2Technology and Practice Services
TypeSubscription Recurring
Description

SaaS-based services including Furscription prescription management, AllyDVM workflow solutions, inventory management, and equipment health monitoring. These subscription and usage-based services complement the core distribution business and create recurring revenue relationships with customers.

mwiah.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1B2B account-based pricing for veterinary practices and producers
ModelOtherBilling cadenceMonthly
Notes

Open account terms available with payment due by 10th of month following invoice date. Credit card accepted with 1.5% processing fee. No publicly listed pricing on website.

mwiah.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1VetOne
Description

Private label brand brought to market by MWI in 2005, providing value and quality products to veterinarians.

mwiah.com
+3 more records
Core offering1 text field

MWI Animal Health distributes pharmaceuticals, vaccines, medications, capital equipment, and office supplies to veterinarians, livestock producers, and animal health manufacturers. The company operates as a B2B animal health distributor with 25,000+ stocked products and 30,000+ drop-ship products sourced from 1,000+ manufacturer partners, complemented by technology-enabled practice solutions including prescription management, equipment health monitoring, and workflow tools.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • First ultra-low temperature cold chain in veterinary medicine enabling -80°C storage and overnight nationwide shipping
+1 more record
Product overview1 text field

MWI Animal Health is a comprehensive animal health distribution company and technology solutions provider operating as a subsidiary of Cencora. The company functions as both a pharmaceutical/medical supply distributor and a technology platform. The core product portfolio includes Furscription (AI-driven prescription management), the MWI Mobile App, and technology-enabled services including Equipment Health Solution, Client Compliance Solutions, Inventory Management, Pharmacy Services, and Workflow Solutions. The company also maintains proprietary brands including VetOne (private label products), Securos Surgical (surgical products), AllyDVM (client communication), and Micro Technologies (data management). The Edwardsville, Kansas distribution center supports over 25,000 stocked products and 30,000+ drop-ship products from 1,000+ manufacturer partners. In 2026, MWI announced a partnership with Gallant to develop the first ultra-low temperature (-80°C) cold chain for veterinary medicine, enabling stem cell therapy distribution.

Product and service14 records
1Furscription
CategoryPharmacy Services
Description

AI-driven prescription management platform that consolidates online and local pharmacy requests into a single system, using artificial intelligence to automate prescription handling, refills, and compliance monitoring for veterinary practices.

2MWI Mobile App
CategoryOrdering and Account Management
Description

Mobile application enabling veterinary customers to access MWI's product catalog, place orders, manage accounts, request returns, and utilize self-service features from iOS and Android devices.

3Equipment Health Solution
CategoryPractice Management Services
Description

Equipment management solution that helps veterinary practices reduce downtime, improve efficiency, and manage all equipment maintenance in one centralized platform to protect patient safety and client trust.

4Client Compliance Solutions
CategoryPractice Management Services
Description

Solutions designed to improve client adherence to treatment protocols and medication regimens, supporting better animal health outcomes through automated reminders and compliance monitoring.

5Inventory Management
CategorySupply Chain Services
Description

Comprehensive inventory control services helping veterinary practices track, order, and manage pharmaceutical and supply inventories efficiently.

6Pharmacy Services
CategoryPharmacy Services
Description

Full-service pharmacy solutions for veterinary practices including prescription fulfillment, compounding services, and pharmacy management integrated with Furscription technology.

7Workflow Solutions
CategoryPractice Management Services
Description

Integrated technology solutions designed to streamline veterinary practice operations and improve overall workflow efficiency.

8AllyDVM
CategoryPractice Management Services
Description

Client communication and engagement platform under MWI's portfolio, providing workflow and communication tools for veterinary practices.

9Micro Technologies
CategoryTechnology Solutions
Description

Technology solutions subsidiary offering animal health data management and technology services for veterinary practices.

10Securos Surgical
CategorySurgical Products
Description

Surgical products brand with over 20 years of experience designing quality surgical products and services for veterinary practices, emphasizing innovation, quality, and personalized service.

11VetOne
CategoryPrivate Label Products
Description

Private label brand offering superior value and quality animal health products to veterinarians, distributed exclusively through authorized sellers with a minimum advertised price policy and product warranty/return policy.

12Ultra-Low Temperature Cold Chain Distribution
CategorySpecialty Distribution
Description

Cold chain distribution service enabling -80°C storage and overnight nationwide shipping of temperature-sensitive advanced therapies, including stem cell treatments, for veterinary practices across the U.S. including Alaska, Hawaii, and Puerto Rico.

13Medications and Supplies Distribution
CategoryPharmaceutical Distribution
Description

Distribution of over 25,000 stocked animal health products and 30,000+ drop-ship items including pharmaceuticals, vaccines, parasiticides, and consumable supplies sourced from 1,000+ manufacturer partners.

14Capital Equipment Distribution
CategoryEquipment Distribution
Description

Distribution of capital equipment for veterinary practices, available through the e-commerce store with account-based ordering and real-time inventory visibility.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-27
Description

Gallant, an animal health biotechnology company, partnered with MWI to create the first ultra-low temperature cold chain in veterinary medicine. MWI developed scalable -80°C fulfillment infrastructure from its Edwardsville, Kansas distribution center, enabling nationwide delivery of Gallant's anticipated FDA-conditionally approved stem cell therapy (sonruvetcel) for cats with refractory feline chronic gingivostomatitis. The partnership extends advanced cell therapy cold-chain rigor into veterinary care and supports Gallant's broader pipeline of disease-modifying stem cell therapies.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-02-18
Description

Covetrus, an animal health technology and services company, agreed to merge with MWI Animal Health in a $3.5 billion deal. The transaction would combine MWI's supply chain infrastructure and distribution capabilities with Covetrus's technology and practice management services, creating one of the largest integrated animal health distribution and technology platforms. Subject to regulatory approval, expected to close after September 2026.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Specialty animal health pharmaceutical company focused on companion animal therapeutics (endocrinology, dermatology, oncology, ophthalmology) — overlaps with MWI's specialty therapeutics distribution niche and shares the same specialty-veterinary customer base.

TypeDirect peer
Description

Animal health distribution and technology platform serving companion and production animal veterinarians in North America and Europe. Direct merger partner with MWI (announced February 2026, $3.5B), combining distribution with practice management software, pharmacy services (VetSource), and workflow tools that closely overlap MWI's offering.

TypeBroad incumbent
Description

Global animal health pharmaceutical manufacturer with a broad companion and livestock portfolio that MWI distributes. A key upstream partner and a potential disintermediator through Elanco's direct sales and digital channels, comparable as a counterparty shaping MWI's catalog breadth.

TypeDirect peer
Description

Global healthcare distribution leader with an Animal Health segment serving companion and production-animal veterinary practices in North America. Competes with MWI in wholesale distribution of veterinary pharmaceuticals, vaccines, equipment, and practice supplies, and offers its own practice software.

TypeBroad incumbent
Description

Dominant veterinary diagnostics, practice management software (Cornerstone), and reference lab provider. Overlaps with MWI's Furscription, AllyDVM, and Micro Technologies software layer and competes to capture the same veterinary practice workflow budget that MWI's distribution-plus-SaaS strategy targets.

TypeDirect peer
Description

Diversified dental and animal health distributor whose Patterson Veterinary Supply segment is one of only three nationwide veterinary distributors in the U.S. — competing head-to-head with MWI for veterinary clinic accounts, capital equipment, and consumable share.

TypeRegional player
Description

Veterinary supply distributor serving companion animal and equine practices across multiple U.S. regions. Comparable to MWI in core wholesale distribution of pharmaceuticals, instruments, and consumables to veterinary clinics.

TypeRegional player
Description

Veterinary distributor serving companion-animal and mixed/livestock practices, primarily across the U.S. Midwest. Operates as the regional counterpart to MWI's nationwide distribution footprint and competes for the same veterinary clinic accounts.

TypeDirect peer
Description

Online veterinary pharmacy and prescription management platform (a Covetrus business) that distributes pharmaceuticals and manages home delivery for veterinary practices. Directly comparable to MWI's pharmacy/prescription business and Furscription Rx management platform.

TypeBroad incumbent
Description

World's largest animal health pharmaceutical manufacturer — a key MWI distribution partner as well as a vertical competitor through direct-to-vet sales (e.g., Vetsource, Zoetis Petcare). Relevant as both a customer/supplier and a potential disintermediation risk for MWI's distribution business.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MWI Animal Health

Veterinary Pharmaceutical Distributionmwiah.com

MWI Animal Health is a US-based animal health distributor and technology solutions provider, wholly owned by Cencora, serving veterinary practices, livestock producers, and manufacturers with 25,000+ stocked SKUs and SaaS workflow tools.

MWI Animal Health firmographics

Firmographics
Name
MWI Animal Health
Legal name
MWI Veterinary Supply Co., d/b/a MWI Animal Health
Website
https://mwiah.com
Company type
Private
Founded year
1976
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
MWI Animal Health is a US-based animal health distributor and technology solutions provider, wholly owned by Cencora, serving veterinary practices, livestock producers, and manufacturers with 25,000+ stocked SKUs and SaaS workflow tools.
Ownership category
akta.pro rank

MWI Animal Health industry classification

Industry
Product category
Veterinary Pharmaceutical Distribution
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)
akta.pro secondary industries
Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Veterinary Inventory, Pharmacy & Medication Management (HLAMAMAF), Animal Health Supply Chain, Procurement & Distributor Connectivity (HLAMAMAK)

Keywords

  • Animal health distribution
  • Veterinary pharmaceuticals
  • Veterinary supply chain
  • Livestock health products
  • Veterinary practice solutions

Where MWI Animal Health is headquartered

Location

Headquarters

HQ city
Boise
HQ country
United States
HQ region
North America

Offices3 records

Markets served

MWI Animal Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Animal Health Product Distribution: MWI distributes over 25,000 stocked products and 30,000+ drop-ship products from 1,000+ manufacturer partners to veterinary practices, livestock producers, and animal health manufacturers. Revenue is generated through product sales at margins typical of distribution, with payment terms including open account (due by 10th of month following invoice) and credit card options.
  2. Technology and Practice Services: SaaS-based services including Furscription prescription management, AllyDVM workflow solutions, inventory management, and equipment health monitoring. These subscription and usage-based services complement the core distribution business and create recurring revenue relationships with customers.

Pricing tiers

ModelBillingPrice
OtherMonthlyB2B account-based pricing for veterinary practices and producers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

MWI Animal Health product offering

Product offering

Core offering

MWI Animal Health distributes pharmaceuticals, vaccines, medications, capital equipment, and office supplies to veterinarians, livestock producers, and animal health manufacturers. The company operates as a B2B animal health distributor with 25,000+ stocked products and 30,000+ drop-ship products sourced from 1,000+ manufacturer partners, complemented by technology-enabled practice solutions including prescription management, equipment health monitoring, and workflow tools.

Product overview

MWI Animal Health is a comprehensive animal health distribution company and technology solutions provider operating as a subsidiary of Cencora. The company functions as both a pharmaceutical/medical supply distributor and a technology platform. The core product portfolio includes Furscription (AI-driven prescription management), the MWI Mobile App, and technology-enabled services including Equipment Health Solution, Client Compliance Solutions, Inventory Management, Pharmacy Services, and Workflow Solutions. The company also maintains proprietary brands including VetOne (private label products), Securos Surgical (surgical products), AllyDVM (client communication), and Micro Technologies (data management). The Edwardsville, Kansas distribution center supports over 25,000 stocked products and 30,000+ drop-ship products from 1,000+ manufacturer partners. In 2026, MWI announced a partnership with Gallant to develop the first ultra-low temperature (-80°C) cold chain for veterinary medicine, enabling stem cell therapy distribution.

Differentiator

Problem solved

Functional benefit

Brands

  • VetOne: Private label brand brought to market by MWI in 2005, providing value and quality products to veterinarians.
  • Securos Surgical
  • AllyDVM
  • Micro Technologies

Products and services

  • Furscription AI-driven prescription management platform that consolidates online and local pharmacy requests into a single system, using artificial intelligence to automate prescription handling, refills, and compliance monitoring for veterinary practices.
  • MWI Mobile App Mobile application enabling veterinary customers to access MWI's product catalog, place orders, manage accounts, request returns, and utilize self-service features from iOS and Android devices.
  • Equipment Health Solution Equipment management solution that helps veterinary practices reduce downtime, improve efficiency, and manage all equipment maintenance in one centralized platform to protect patient safety and client trust.
  • Client Compliance Solutions Solutions designed to improve client adherence to treatment protocols and medication regimens, supporting better animal health outcomes through automated reminders and compliance monitoring.
  • Inventory Management Comprehensive inventory control services helping veterinary practices track, order, and manage pharmaceutical and supply inventories efficiently.
  • Pharmacy Services Full-service pharmacy solutions for veterinary practices including prescription fulfillment, compounding services, and pharmacy management integrated with Furscription technology.
  • Workflow Solutions Integrated technology solutions designed to streamline veterinary practice operations and improve overall workflow efficiency.
  • AllyDVM Client communication and engagement platform under MWI's portfolio, providing workflow and communication tools for veterinary practices.
  • Micro Technologies Technology solutions subsidiary offering animal health data management and technology services for veterinary practices.
  • Securos Surgical Surgical products brand with over 20 years of experience designing quality surgical products and services for veterinary practices, emphasizing innovation, quality, and personalized service.
  • VetOne Private label brand offering superior value and quality animal health products to veterinarians, distributed exclusively through authorized sellers with a minimum advertised price policy and product warranty/return policy.
  • Ultra-Low Temperature Cold Chain Distribution Cold chain distribution service enabling -80°C storage and overnight nationwide shipping of temperature-sensitive advanced therapies, including stem cell treatments, for veterinary practices across the U.S. including Alaska, Hawaii, and Puerto Rico.
  • Medications and Supplies Distribution Distribution of over 25,000 stocked animal health products and 30,000+ drop-ship items including pharmaceuticals, vaccines, parasiticides, and consumable supplies sourced from 1,000+ manufacturer partners.
  • Capital Equipment Distribution Distribution of capital equipment for veterinary practices, available through the e-commerce store with account-based ordering and real-time inventory visibility.

Quantifiable outcome

  • First ultra-low temperature cold chain in veterinary medicine enabling -80°C storage and overnight nationwide shipping
  • +1 more outcomes

Companies that use MWI Animal Health

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles5 records

MWI Animal Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

MWI Animal Health partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • GallantcoreStrategic or Co-development Partner · 27 February 2026Gallant, an animal health biotechnology company, partnered with MWI to create the first ultra-low temperature cold chain in veterinary medicine. MWI developed scalable -80°C fulfillment infrastructure from its Edwardsville, Kansas distribution center, enabling nationwide delivery of Gallant's anticipated FDA-conditionally approved stem cell therapy (sonruvetcel) for cats with refractory feline chronic gingivostomatitis. The partnership extends advanced cell therapy cold-chain rigor into veterinary care and supports Gallant's broader pipeline of disease-modifying stem cell therapies.
  • CovetrusflagshipStrategic or Co-development Partner · 18 February 2026Covetrus, an animal health technology and services company, agreed to merge with MWI Animal Health in a $3.5 billion deal. The transaction would combine MWI's supply chain infrastructure and distribution capabilities with Covetrus's technology and practice management services, creating one of the largest integrated animal health distribution and technology platforms. Subject to regulatory approval, expected to close after September 2026.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

MWI Animal Health competitors and assessment

Company assessment

Broad incumbents

  • Dechra Pharmaceuticals: Specialty animal health pharmaceutical company focused on companion animal therapeutics (endocrinology, dermatology, oncology, ophthalmology) — overlaps with MWI's specialty therapeutics distribution niche and shares the same specialty-veterinary customer base.
  • Elanco Animal Health: Global animal health pharmaceutical manufacturer with a broad companion and livestock portfolio that MWI distributes. A key upstream partner and a potential disintermediator through Elanco's direct sales and digital channels, comparable as a counterparty shaping MWI's catalog breadth.
  • IDEXX Laboratories: Dominant veterinary diagnostics, practice management software (Cornerstone), and reference lab provider. Overlaps with MWI's Furscription, AllyDVM, and Micro Technologies software layer and competes to capture the same veterinary practice workflow budget that MWI's distribution-plus-SaaS strategy targets.
  • Zoetis: World's largest animal health pharmaceutical manufacturer — a key MWI distribution partner as well as a vertical competitor through direct-to-vet sales (e.g., Vetsource, Zoetis Petcare). Relevant as both a customer/supplier and a potential disintermediation risk for MWI's distribution business.

Direct peers

  • Covetrus: Animal health distribution and technology platform serving companion and production animal veterinarians in North America and Europe. Direct merger partner with MWI (announced February 2026, $3.5B), combining distribution with practice management software, pharmacy services (VetSource), and workflow tools that closely overlap MWI's offering.
  • Henry Schein: Global healthcare distribution leader with an Animal Health segment serving companion and production-animal veterinary practices in North America. Competes with MWI in wholesale distribution of veterinary pharmaceuticals, vaccines, equipment, and practice supplies, and offers its own practice software.
  • Patterson Companies: Diversified dental and animal health distributor whose Patterson Veterinary Supply segment is one of only three nationwide veterinary distributors in the U.S. — competing head-to-head with MWI for veterinary clinic accounts, capital equipment, and consumable share.
  • VetSource: Online veterinary pharmacy and prescription management platform (a Covetrus business) that distributes pharmaceuticals and manages home delivery for veterinary practices. Directly comparable to MWI's pharmacy/prescription business and Furscription Rx management platform.

Regional players

  • Victor Medical Company: Veterinary supply distributor serving companion animal and equine practices across multiple U.S. regions. Comparable to MWI in core wholesale distribution of pharmaceuticals, instruments, and consumables to veterinary clinics.
  • Midwest Veterinary Supply: Veterinary distributor serving companion-animal and mixed/livestock practices, primarily across the U.S. Midwest. Operates as the regional counterpart to MWI's nationwide distribution footprint and competes for the same veterinary clinic accounts.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights5 records

Customer concentration

MWI Animal Health social profiles

Digital presence

MWI Animal Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MWI Animal Health leadership team

Management profile

Number of profiles

Profiles1 record

MWI Animal Health subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

MWI Animal Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MWI Animal Health M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MWI Animal Health

What does MWI Animal Health do?

MWI Animal Health distributes pharmaceuticals, vaccines, medications, capital equipment, and office supplies to veterinarians, livestock producers, and animal health manufacturers. The company operates as a B2B animal health distributor with 25,000+ stocked products and 30,000+ drop-ship products sourced from 1,000+ manufacturer partners, complemented by technology-enabled practice solutions including prescription management, equipment health monitoring, and workflow tools.

Is MWI Animal Health a public or private company?

MWI Animal Health is a private company. It is classified as corporate owned and is currently operating.

When was MWI Animal Health founded?

MWI Animal Health was founded in 1976. It employs 1,001 to 5,000 people.

Where is MWI Animal Health based?

MWI Animal Health is headquartered in Boise, United States, in the North America region.

How does MWI Animal Health make money?

Two revenue lines are on record. Animal Health Product Distribution is the primary driver. The others are technology and Practice Services.

Who are MWI Animal Health's main competitors?

Broad incumbents on record are Dechra Pharmaceuticals, Elanco Animal Health, IDEXX Laboratories and Zoetis. Direct peers are Covetrus, Henry Schein, Patterson Companies and VetSource. Regional players are Victor Medical Company and Midwest Veterinary Supply.

Does MWI Animal Health have an API?

No public API is recorded for MWI Animal Health.

What industry is MWI Animal Health in?

MWI Animal Health's product category is Veterinary Pharmaceutical Distribution. Its primary akta.pro industry code is HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors, with a secondary code of HLAMAIAC, Veterinary Vaccine & Biologics Distributors. Its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireVeterinary Monitoring Equipment Market worth $1.03 billion by 2031 - Exclusive Report by MarketsandMarkets™The veterinary monitoring equipment market is projected to grow from USD 0.69 billion in 2026 to USD 1.03 billion by 2031, a CAGR of 8.3%. Multiparameter monitors hold the largest segment share, and companion animals are the fastest-growing animal type, with Asia Pacific expected to see the highest regional growth.Seeking AlphaCencora outlines fiscal 2026 EPS of $17.75-$17.95 while maintaining ~$3B free cash flow target (NYSE:COR)Cencora reported strong Q3 fiscal 2026 results, raising full-year adjusted EPS guidance to $17.75-$17.95 from $17.70-$17.90, driven by 12% EPS growth and 17% adjusted operating income growth. Revenue reached $84.8 billion, up 5% year-over-year, while the company completed $1 billion in share repurchases at an average price of $268 per share and maintained its approximately $3 billion free cash flow target. Looking ahead, management flagged potential fiscal 2027 headwinds related to the MWI Animal Health/Covetrus transaction timing and noted uncertainty around the EyeSouth Retina carve-out acquisition schedule.AInvestFTC takes closer look at merger of vet products distributors Covetrus and MWI Animal Health, a unit of Cencora - Bloomberg NewsThe U.S. Federal Trade Commission has initiated a detailed antitrust review of the proposed merger between Covetrus and MWI Animal Health, issuing civil investigative demands to customers and market participants to assess competitive effects. The merger, announced in February 2026, values MWI at $3.5 billion, with Cencora to receive $1.25 billion cash, preferred equity, and a 34.3% non-controlling stake in the combined entity. The FTC's scrutiny highlights significant regulatory challenges that remain before the deal can be finalized, making the outcome of this review a key factor in determining the transaction's timeline and success.BloombergFTC Reviews Covetrus, MWI Animal Health Merger for Antitrust Concerns - BloombergThe US Federal Trade Commission is reviewing a proposed $3.5 billion acquisition that would combine veterinary products distributors Covetrus Inc. and MWI Animal Health, sending information demands to customers and rivals of both companies. The antitrust probe focuses on how the deal would impact the availability of veterinary products and practice-management software used by clinics. MWI Animal Health is a unit of Cencora Inc., making it a parent-subsidiary transaction within the veterinary distribution sector.AahaReclaiming lost hours: How digital prescription management is reshaping veterinary workflowsMWI Animal Health published a sponsored article detailing how cloud-based digital prescription platforms, such as Furscription, are replacing manual workflows in veterinary practices to save staff time and reduce errors. The piece highlights that these systems can cut prescription management hours by 30-40 percent, citing efficiency gains reported by First Data Bank. It outlines operational benefits including improved compliance, safety safeguards, and reduced administrative burden on veterinary teams.Business Wire BlogCencora Reports Fiscal 2026 Second Quarter ResultsCencora reported fiscal 2026 Q2 revenue of $78.4 billion, up 3.8% year-over-year, with adjusted diluted EPS of $4.75. The company raised its fiscal 2026 adjusted EPS guidance to $17.65-$17.90 and expects to repurchase $1 billion in shares by end of calendar 2026.PR NewswireAnimal Drug Compounding Market to Reach US$ 2.3 Billion by 2033, Expands Amid Rising Pet Healthcare Demand and Personalized Veterinary Medicine - Persistence Market ResearchThe global animal drug compounding market is projected to grow from US$1.5 billion in 2026 to US$2.3 billion by 2033, with a CAGR of 6.6%, driven by rising pet ownership, increasing veterinary healthcare expenditure, and demand for personalized medication formulations. North America leads the market with a 42% share, while Asia Pacific emerges as the fastest-growing region; CNS agents dominate product types at 33% of revenue. A key development in 2026 is the $3.5 billion strategic merger between Cencora and Covetrus, combining MWI Animal Health with Covetrus to form an integrated animal health distribution and technology platform.YahooAnimal Drug Compounding Market to Reach US$ 2.3 Billion by 2033, Expands Amid Rising Pet Healthcare Demand and Personalized Veterinary Medicine - Persistence Market ResearchThe global animal drug compounding market is projected to grow from approximately US$1.5 billion in 2026 to US$2.3 billion by 2033 at a CAGR of 6.6%, driven by rising pet ownership, increasing veterinary healthcare expenditure, and demand for personalized medication formulations for animals. A major development in 2026 was Cencora's announcement to merge its subsidiary MWI Animal Health with Covetrus in a $3.5 billion deal, combining animal health distribution networks with technology and service capabilities to create an integrated veterinary supply chain platform. North America leads the market with a 42% share while Asia Pacific emerges as the fastest-growing regional market, supported by rising urbanization and expanding pet adoption across China, India, Japan, and Australia.GrataThe PE Playbook: Pet CareThis Grata report provides a comprehensive overview of the pet care industry for private equity investors, highlighting a $150B US market projected to reach $500B globally by 2030, with M&A activity that peaked in 2022 during the pandemic pet adoption boom and has since normalized. Key findings show private grooming companies lead growth at 56.9%, pet insurance generates the highest average revenue, and the veterinary services sector remains highly fragmented with over 40,000 private companies available for acquisition. The report documents several recent acquisitions including Rover Group's purchase of Meowtel, Covetrus's $3.5B acquisition of MWI Animal Health, and Nasta.Com's $142M purchase of FirstMate Pet Foods.PR NewswireAnimal Drug Compounding Market to Reach US$ 2.3 Billion by 2033, Expands Amid Rising Pet Healthcare Demand and Personalized Veterinary Medicine - Persistence Market ResearchThe global animal drug compounding market is projected to grow from US$1.5 billion in 2026 to US$2.3 billion by 2033, with a CAGR of 6.6%, driven by rising pet ownership, increasing veterinary healthcare expenditure, and demand for personalized medication formulations. A key development in 2026 was the announcement that Cencora will merge its animal health subsidiary MWI Animal Health with Covetrus in a $3.5 billion deal, forming a combined animal health distribution and technology platform. North America leads with 42% market share while Asia Pacific emerges as the fastest-growing region, supported by rising pet adoption and urbanization.